TH43276A - - Google Patents
Info
- Publication number
- TH43276A TH43276A TH9801001491A TH9801001491A TH43276A TH 43276 A TH43276 A TH 43276A TH 9801001491 A TH9801001491 A TH 9801001491A TH 9801001491 A TH9801001491 A TH 9801001491A TH 43276 A TH43276 A TH 43276A
- Authority
- TH
- Thailand
- Prior art keywords
- protein
- approximately
- activetec
- formulation
- sucrose
- Prior art date
Links
- 101800004937 Protein C Proteins 0.000 claims abstract 6
- 102100036546 Salivary acidic proline-rich phosphoprotein 1/2 Human genes 0.000 claims abstract 6
- 101800001700 Saposin-D Proteins 0.000 claims abstract 6
- 229960000856 protein c Drugs 0.000 claims abstract 6
- 229930006000 Sucrose Natural products 0.000 claims abstract 5
- 239000005720 sucrose Substances 0.000 claims abstract 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract 4
- 239000000203 mixture Substances 0.000 claims abstract 4
- 229940079593 drug Drugs 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 239000000126 substance Substances 0.000 claims 3
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims 2
- 235000013372 meat Nutrition 0.000 claims 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims 1
- 101710117545 C protein Proteins 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 125000000185 sucrose group Chemical group 0.000 claims 1
- -1 terehaloose Chemical compound 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 4
- 238000009472 formulation Methods 0.000 abstract 3
- 239000011780 sodium chloride Substances 0.000 abstract 2
- 239000001509 sodium citrate Substances 0.000 abstract 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract 2
- 239000013583 drug formulation Substances 0.000 abstract 1
- 210000000003 hoof Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH43276A true TH43276A (de) | 2001-02-23 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2025027I1 (no) | Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget. | |
| CA2288143A1 (en) | Activated protein c formulations | |
| WO2002051390A3 (en) | Amphiphilic lipid nanoparticles for peptide and/or protein incorporation | |
| IT8848441A0 (it) | Derivato di 4h-benzopiran-4-one o suo sale, procedimento per produrlo e composizione farmaceutica che lo contiene come ingrediente attivo | |
| RU93004902A (ru) | Композиция пролонгированного контролируемого высвобождения пептидного лекарственного вещества и способ ее получения | |
| ES2569228T3 (es) | Formulaciones de formas farmacéuticas sólidas de fentanilo que tienen mejor adsorción bucal | |
| DE69534538D1 (de) | Verzögerte Freisetzung von Peptiden aus pharmazeutischen Zusammensetzungen | |
| FR2805818B1 (fr) | Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant | |
| ES2062417T3 (es) | Composiciones farmaceuticas de cimetidina. | |
| DE69812949D1 (de) | Hydroxamsäurederivat und antitumormittel enthaltende pharmazeutische zusammensetzung mit verbesserter antitumor-aktivität und/oder verringerten nebenwirkungen | |
| BR9607410A (pt) | Soluções farmacêuticas salinas não inorgânicas para administração endonasal | |
| ATE332138T1 (de) | Flibanserin zur behandlung extrapyramidaler bewegungsstörungen | |
| FI914919A7 (fi) | AIDS-potilaiden neurologisten sairauksien hoidossa tehokkaat farmaseuttiset koostumukset, jotka sisältävät vaikuttavana aineena vähintään yhtä yhdistettä, joka on valittu ryhmästä, joka käsittää S-adenosyyli -L-metioniinisuolan, 5-metyylitetrahydrofool | |
| IT1314185B1 (it) | Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi | |
| JP2000159790A5 (de) | ||
| FR2796380B3 (fr) | Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant | |
| TH43276A (de) | ||
| RU96120655A (ru) | Композиция для профилактики и лечения гриппа и орви | |
| RU94040865A (ru) | Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью | |
| AR022338A1 (es) | Un compuesto de benzamida, medicamento que lo contiene, y uso para la manufactura de un medicamento para el tratamiento o prevencion de una enfermedad digestiva o para mejorar la movilidad del tracto gastrointestinal. | |
| WO2001045727A3 (en) | Stabilized veterinary compositions comprising more than one antiviral agent | |
| FR2751967B1 (fr) | Agents antipaludeens et antibabesioses et compositions pharmaceutiques les contenant | |
| FR2789078B3 (fr) | Derives d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant | |
| EP0182772A3 (de) | Arzneimittel mit verlängerter Freigabe, Verfahren zu deren Herstellung sowie deren Verwendung | |
| FR2840898B1 (fr) | Derives hydrazide ou hydrazone de l'acide hexahydropyridazine-3-carboxylique, chimiotheques et compositions pharmaceutiques les contenant, utilisation comme medicaments, et procede de preparation |